Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert D Fechtner

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Journal of Glaucoma|June 29, 2013
Intraocular pressure outcomes after endophthalmitis associated with glaucoma surgeryRana J Mady, Bart K Holland, Neelakshi Bhagat, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 13, 2006
Short-term treatment of cocaine and/or methamphetamine abuse with vigabatrin: ocular safety pilot resultsRobert D Fechtner, Albert S Khouri, Emilia Figueroa, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 28, 2011
Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprostRobert D Fechtner, Paul Harasymowycz, Donald R Nixon, et al.
Ophthalmology|September 8, 2007
Corneal thickness measurement in the management of primary open-angle glaucoma: a report by the American Academy of OphthalmologyDavid K Dueker, Kuldev Singh, Shan C Lin, et al.
Oman Journal of Ophthalmology|May 5, 2012
Pars plana Baerveldt tube insertion with pars plana vitrectomy for refractory glaucomaAnton M Kolomeyer, H Jane Kim, Albert S Khouri, et al.
Ophthalmology|November 8, 2018
24-Hour Intraocular Pressure Control with Fixed-dose Combination Brinzolamide 1%/Brimonidine 0.2%: A Multicenter, Randomized TrialRobert N Weinreb, Jason Bacharach, Robert D Fechtner, et al.
Journal of Glaucoma|April 8, 2022
A Randomized, Controlled Comparison of NCX 470 (0.021%, 0.042%, and 0.065%) and Latanoprost 0.005% in Patients With Open-angle Glaucoma or Ocular Hypertension: The Dolomites StudyThomas R Walters, Angela C Kothe, José L Boyer, et al.
Retina (Philadelphia, Pa.)|January 11, 2008
Short-term complications of intravitreal injection of triamcinolone acetonideDaniel B Roth, Tony Realini, William J Feuer, et al.
Ophthalmology. Glaucoma|July 17, 2020
Five-Year, Prospective, Randomized, Multi-Surgeon Trial of Two Trabecular Bypass Stents versus Prostaglandin for Newly Diagnosed Open-Angle GlaucomaRobert D Fechtner, Lilit Voskanyan, Steven D Vold, et al.
Journal of Glaucoma|August 23, 2020
Pooled Efficacy and Safety Profile of Netarsudil Ophthalmic Solution 0.02% in Patients With Open-angle Glaucoma or Ocular HypertensionInder P Singh, Robert D Fechtner, Jonathan S Myers, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Journal of Glaucoma|June 29, 2013
Intraocular pressure outcomes after endophthalmitis associated with glaucoma surgeryRana J Mady, Bart K Holland, Neelakshi Bhagat, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 13, 2006
Short-term treatment of cocaine and/or methamphetamine abuse with vigabatrin: ocular safety pilot resultsRobert D Fechtner, Albert S Khouri, Emilia Figueroa, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 28, 2011
Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprostRobert D Fechtner, Paul Harasymowycz, Donald R Nixon, et al.
Ophthalmology|September 8, 2007
Corneal thickness measurement in the management of primary open-angle glaucoma: a report by the American Academy of OphthalmologyDavid K Dueker, Kuldev Singh, Shan C Lin, et al.
Oman Journal of Ophthalmology|May 5, 2012
Pars plana Baerveldt tube insertion with pars plana vitrectomy for refractory glaucomaAnton M Kolomeyer, H Jane Kim, Albert S Khouri, et al.
Ophthalmology|November 8, 2018
24-Hour Intraocular Pressure Control with Fixed-dose Combination Brinzolamide 1%/Brimonidine 0.2%: A Multicenter, Randomized TrialRobert N Weinreb, Jason Bacharach, Robert D Fechtner, et al.
Journal of Glaucoma|April 8, 2022
A Randomized, Controlled Comparison of NCX 470 (0.021%, 0.042%, and 0.065%) and Latanoprost 0.005% in Patients With Open-angle Glaucoma or Ocular Hypertension: The Dolomites StudyThomas R Walters, Angela C Kothe, José L Boyer, et al.
Retina (Philadelphia, Pa.)|January 11, 2008
Short-term complications of intravitreal injection of triamcinolone acetonideDaniel B Roth, Tony Realini, William J Feuer, et al.
Ophthalmology. Glaucoma|July 17, 2020
Five-Year, Prospective, Randomized, Multi-Surgeon Trial of Two Trabecular Bypass Stents versus Prostaglandin for Newly Diagnosed Open-Angle GlaucomaRobert D Fechtner, Lilit Voskanyan, Steven D Vold, et al.
Journal of Glaucoma|August 23, 2020
Pooled Efficacy and Safety Profile of Netarsudil Ophthalmic Solution 0.02% in Patients With Open-angle Glaucoma or Ocular HypertensionInder P Singh, Robert D Fechtner, Jonathan S Myers, et al.
Pageof 5